An observational study in Poor Oral Intake, Percutaneous Endoscopic Gastrostomy and Nutrition Disorders, sponsored by Sisli Hamidiye Etfal Training and Research Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-08.
Sponsored by Sisli Hamidiye Etfal Training and Research Hospital · Observational
Nutrition is the intake of essential nutrients in sufficient quantities and at the appropriate times to maintain and improve health and enhance quality of life.
Enteral nutrition is superior to parenteral nutrition and should be preferred. Patients should begin enteral nutrition as soon as possible to protect the gastrointestinal mucosa and maintain normal flora. In patients unable to take food orally, enteral nutrition is provided via a nasogastric/nasojejunal tube or gastrostomy tube.
Gastrostomy is the first choice for patients with a functional gastrointestinal system, poor oral intake, and requiring long-term nutritional support. Feeding tubes can be placed percutaneously or surgically. Percutaneous endoscopic gastrostomy (PEG) is a minimally invasive procedure that does not increase morbidity or mortality compared to surgical gastrostomy, and is cheaper and more time-saving. It was first applied in 1980 as an alternative to surgical gastrostomy. Initially described, a line was drawn between the umblicus and the middle of the left lower costal margin, and a feeding tube was inserted under local anesthesia at the junction of the middle 2/3 and the outer 1/3, with feeding starting the next day. Vudayagiri et al. reported that the placement site is generally 2 cm medial to the costal margin and 2 cm below the xiphoid process.
Different methods for placing a PEG tube into the stomach (pull technique, push technique, and Russell method) are described in the literature, with the most common being the "pull" technique. The 2005 ESPEN guidelines note that in the "pull" technique, gastroscopic visualization of the anterior gastric wall is performed, followed by determination of the puncture site at the distal corpus level.
The exact placement of the PEG feeding tube, both on the skin and within the gastric lumen, is not fully understood. Its localization on the abdominal skin will be optimally determined by endoscopic transillumination. However, its level within the gastric lumen is predictable.
In our study, we aimed to measure the distance of the feeding tube from the pylorus in patients undergoing PEG surgery, to investigate how this affects post-procedure outcomes, and to determine the optimal level within the gastric lumen. Additionally, the catheter placement on the skin will be recorded for each patient. The anatomical skin localization obtained by examining the data of all patients will be defined as the 'Triangle of Çaykara'.
233 studies on the registry are indexed under Nutrition Disorders; 26 are open to participants now.
This study's planned enrollment of 200 is above the median of 108 across 57 observational studies indexed under Nutrition Disorders.
Browse Nutrition Disorders studies →Sisli Hamidiye Etfal Training and Research Hospital is the lead sponsor of 114 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Demographic, clinical, and postoperative data of patients who will undergo PEG procedures in our hospital's surgical endoscopy unit between September 1, 2026, and September 1, 2027, as indicated by neurology, gastroenterology, and intensive care physicians, will be examined.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Shortest tube-to-pylorus distance
Procedure: Percutaneous endoscopic gastrostomy
Intermediate tube-to-pylorus distance
Procedure: Percutaneous endoscopic gastrostomy
Greatest tube-to-pylorus distance
Procedure: Percutaneous endoscopic gastrostomy
The exact placement of the PEG feeding tube, both on the skin and within the gastric lumen, is not fully understood. In this study, researchers aimed to measure the distance of the feeding tube from the pylorus in patients undergoing PEG surgery, investigate how this affects post-procedure outcomes, and determine the optimal level within the gastric lumen. Additionally, the catheter placement on the skin will be recorded for each patient. The anatomical skin localization obtained by analyzing data from all patients will be defined as the 'Çaykara Triangle'.
Surgery-related complications
Incidence of procedure-related and early post-procedure complications
Time frame: From the procedure through the first 2 weeks
Feeding tolerance
Intolerance to enteral nutrition is typically defined by gastrointestinal symptoms such as vomiting, excessive gastric residual volumes (typically \>500 mL over 6 hours), abdominal distension, diarrhea, or constipation. All these parameters will be recorded, but particular attention will be paid to measuring excessive volumes of gastric residue.
Time frame: Daily monitoring starting 24 hours after the procedure and continuing for the first 2 weeks.
Tube-to-pylorus distance (cm)
This is achieved by advancing a marked catheter through the PEG tube immediately after insertion, and simultaneously performing endoscopy. The distance to the pylorus is measured in centimeters.
Time frame: At the time of the procedure
PEG tube placement site on the skin
Determining PEG localization on the anterior abdominal wall using the xiphoid process, umbilicus, and costal margin as reference points. The anatomical skin localization obtained by examining the data of all patients will be defined as the 'Triangle of Çaykara'.
Time frame: At the time of the procedure
No study locations are listed for this record.
Start is estimated for Aug 2026; primary completion for Aug 2027, 12 months later.
Of 26 observational studies under Nutrition Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 60. This study's planned 12 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sisli Hamidiye Etfal Training and Research Hospital →